rs10555297
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001103146.3(GIGYF2):βc.3630_3632delβ(p.Gln1216del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.574 in 1,526,600 control chromosomes in the GnomAD database, including 244,405 homozygotes. Variant has been reported in ClinVar as Benign (β ). Synonymous variant affecting the same amino acid position (i.e. P1210P) has been classified as Benign.
Frequency
Genomes: π 0.61 ( 25547 hom., cov: 0)
Exomes π: 0.57 ( 218858 hom. )
Consequence
GIGYF2
NM_001103146.3 inframe_deletion
NM_001103146.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.44
Genes affected
GIGYF2 (HGNC:11960): (GRB10 interacting GYF protein 2) This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 2-232847516-CACA-C is Benign according to our data. Variant chr2-232847516-CACA-C is described in ClinVar as [Benign]. Clinvar id is 518338.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr2-232847516-CACA-C is described in Lovd as [Likely_benign]. Variant chr2-232847516-CACA-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.636 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GIGYF2 | NM_001103146.3 | c.3630_3632del | p.Gln1216del | inframe_deletion | 27/29 | ENST00000373563.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GIGYF2 | ENST00000373563.9 | c.3630_3632del | p.Gln1216del | inframe_deletion | 27/29 | 1 | NM_001103146.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.612 AC: 87265AN: 142576Hom.: 25523 Cov.: 0
GnomAD3 genomes
AF:
AC:
87265
AN:
142576
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.557 AC: 129291AN: 232056Hom.: 37165 AF XY: 0.541 AC XY: 68565AN XY: 126696
GnomAD3 exomes
AF:
AC:
129291
AN:
232056
Hom.:
AF XY:
AC XY:
68565
AN XY:
126696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.570 AC: 789195AN: 1383896Hom.: 218858 AF XY: 0.562 AC XY: 386735AN XY: 688594
GnomAD4 exome
AF:
AC:
789195
AN:
1383896
Hom.:
AF XY:
AC XY:
386735
AN XY:
688594
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.612 AC: 87347AN: 142704Hom.: 25547 Cov.: 0 AF XY: 0.613 AC XY: 42699AN XY: 69682
GnomAD4 genome
AF:
AC:
87347
AN:
142704
Hom.:
Cov.:
0
AF XY:
AC XY:
42699
AN XY:
69682
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Parkinson disease 11, autosomal dominant, susceptibility to Benign:1
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at